Literature DB >> 20456003

Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease.

Young Shin Ryu1, So Young Park, Min-Su Jung, Song-Hee Yoon, Mi-Yang Kwen, Sun-Young Lee, Sun-Hee Choi, Chinzorig Radnaabazar, Mi-Kyoung Kim, Hangun Kim, Kwonseop Kim, Woo-Joo Song, Sul-Hee Chung.   

Abstract

The dual-specificity tyrosine(Y)-phosphorylation-regulated kinase 1A (Dyrk1A) gene is located on human chromosome 21 and encodes a proline-directed protein kinase that might be responsible for mental retardation and early onset of Alzheimer's disease (AD) in Down syndrome (DS) patients. Presenilin 1 (PS1) is a key component of the γ-secretase complex in the generation of β-amyloid (Aβ), an important trigger protein in the pathogenesis of AD. Increased Dyrk1A expression has been reported in human AD and DS brains. We previously showed that Dyrk1A increased Aβ production in mammalian cells and transgenic mice that over-express Dyrk1A. In this study, we describe a potential mechanism by which Aβ is increased in Dyrk1A-over-expressing DS and AD brains. First, we show that PS1 is phosphorylated by the Dyrk1A at Thr(354) and that this phosphorylation increases γ-secretase activity. Then, using transgenic mice that over-express human Dyrk1A, we demonstrate that phospho-Thr354-PS1 (pT354-PS1) expression is enhanced when Dyrk1A level is increased. We also show that pT354-PS1 is more stable than the unphosphorylated form of PS1. These results reveal a potential regulatory link between Dyrk1A and PS1 in the Aβ pathway of DS and AD brains, suggesting that up-regulated Dyrk1A may accelerate AD pathogenesis through PS1 phosphorylation.
© 2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456003     DOI: 10.1111/j.1471-4159.2010.06769.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  32 in total

1.  Mice deficient in cystathionine beta synthase display increased Dyrk1A and SAHH activities in brain.

Authors:  Chris Planque; Julien Dairou; Christophe Noll; Linh-Chi Bui; Clémentine Ripoll; Fayçal Guedj; Jean-Maurice Delabar; Nathalie Janel
Journal:  J Mol Neurosci       Date:  2012-06-15       Impact factor: 3.444

2.  Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.

Authors:  Min-Su Jung; Jung-Hwa Park; Young Shin Ryu; Sun-Hee Choi; Song-Hee Yoon; Mi-Yang Kwen; Ji Youn Oh; Woo-Joo Song; Sul-Hee Chung
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

3.  Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).

Authors:  Woo-Joo Song; Eun-Ah Christine Song; Min-Su Jung; Sun-Hee Choi; Hyung-Hwan Baik; Byung Kwan Jin; Jeong Hee Kim; Sul-Hee Chung
Journal:  J Biol Chem       Date:  2014-12-04       Impact factor: 5.157

4.  Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study.

Authors:  Mir Mohammad Shahroz; Hemant Kumar Sharma; Abdulmalik S A Altamimi; Mubarak A Alamri; Abuzer Ali; Amena Ali; Safar Alqahtani; Ali Altharawi; Alhumaidi B Alabbas; Manal A Alossaimi; Yassine Riadi; Ahmad Firoz; Obaid Afzal
Journal:  Molecules       Date:  2022-02-09       Impact factor: 4.411

5.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

Review 6.  Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.

Authors:  Akanksha Kulshreshtha; Poonam Piplani
Journal:  Neurol Sci       Date:  2016-06-01       Impact factor: 3.307

Review 7.  Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?

Authors:  Breland Smith; Federico Medda; Vijay Gokhale; Travis Dunckley; Christopher Hulme
Journal:  ACS Chem Neurosci       Date:  2012-08-28       Impact factor: 4.418

Review 8.  Protease regulation: the Yin and Yang of neural development and disease.

Authors:  Ge Bai; Samuel L Pfaff
Journal:  Neuron       Date:  2011-10-06       Impact factor: 17.173

9.  Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A.

Authors:  Stefania Sarno; Marco Mazzorana; Ryan Traynor; Maria Ruzzene; Giorgio Cozza; Mario A Pagano; Flavio Meggio; Giuseppe Zagotto; Roberto Battistutta; Lorenzo A Pinna
Journal:  Cell Mol Life Sci       Date:  2011-07-01       Impact factor: 9.261

Review 10.  Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control.

Authors:  Walter Becker
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.